[{"Assets_0_Q3_USD":152187000.0,"CommonStockSharesOutstanding_0_Q3_shares":31640672.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-19345000.0,"NetIncomeLoss_1_Q3_USD":-7673000.0,"NetIncomeLoss_3_Q3_USD":-24178000.0,"StockholdersEquity_0_Q3_USD":143239000.0,"Ticker":"REPL","CIK":"1737953","name":"REPLIMUNE GROUP, INC.","OfficialName":"Replimune Group Inc. Common Stock","form":"10-Q","period":"20181231","fy":"2018.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"857797433.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20190214"}]